Clinical Trials Directory

Trials / Completed

CompletedNCT04989296

Informative Value of Determining the Level of NF-κB Translocation in Lymphocyte Populations in Children With Psoriasis

Informative Value of Determining the Level of NF-κB Translocation by Flow Cytometry With Visualization in Lymphocyte Populations in Children With Psoriasis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
National Medical Research Center for Children's Health, Russian Federation · Other Government
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Accepted

Summary

This study is the first to quantify the level of NF-kB translocation in lymphocyte populations in children and adolescents with psoriasis of varying severity.

Detailed description

This is a diagnostic study aimed at finding immunological predictors of the effectiveness of therapy in children and adolescents with psoriasis. The study included 90 patients from 1 to 18 years old with psoriasis vulgaris, mild / moderate and severe. The comparison group consisted of 30 healthy children. The study took into account the PASI (Psoriasis Area Severity Index); the BSA (Body Surface Area); including patient age; duration of the disease; type of therapy; duration of therapy. Depending on the type of therapy, all psoriatic children were divided into 3 groups: Group 1 (n = 24) - patients receiving basic and external therapy; Group 2 (n = 20) - patients receiving systemic therapy with methotrexate; and Group 3 (n = 46) - patients receiving therapy with genetically engineered biological drugs (Adalimumab, Etanercept, Ustekinumab). The analysis of the NF-κB translocation level in lymphocytes was performed by flow cytometry with imaging (Image Stream Mark II - AMNIS) using the Amnis NF-κB Translocation Kit.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPeripheral blood samples were obtained following the standard procedures.Taking 4 ml of peripheral blood from patients on an empty stomach.

Timeline

Start date
2018-09-01
Primary completion
2019-11-20
Completion
2020-01-15
First posted
2021-08-04
Last updated
2021-08-04

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT04989296. Inclusion in this directory is not an endorsement.